Furthermore, there is a negative correlation between the amount of MIF and the effectiveness of PD‐1 blockade immunotherapy when used in conjunction with chemotherapy as a neoadjuvant treatment for esophageal squamous cell carcinoma.61 This evidence concerns the gene MIF and esophageal squamous cell carcinoma.